Michaël Schnekenburger

Author

Also Known As

A. D. Windhorst, M SCHNEKENBURGER, M. SCHNEKENBURGER, M. Schnekenburger, MICHAEL SCHNEKENBURGER, MICHAËL SCHNEKENBURGER, Michael Schnekenburger, Michaël Schnekenburger, Schnekenburger, Michael

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Hôpital Kirchberg Seoul National University Centre National de la Recherche Scientifique Université de Lorraine University of Cincinnati Medical Center

About

Michaël Schnekenburger is an author at Hôpital Kirchberg specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	40	2.3K
2	Natural Sciences	16	16	1.1K
3	Biochemistry	12	12	566
4	Health Sciences	3	3	169
5	Biomolecular Engineering	1	1	40

Michaël Schnekenburger

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Long term low-dose arsenic exposure induces loss of DNA methylation John F. Reichard, Michaël Schnekenburger, Alvaro Puga Biochemical and Biophysical Research Communications ChromatinMedicineGeneticsDna MethylationNatural Sciences	2006	300
Chromium Cross-Links Histone Deacetylase 1-DNA Methyltransferase 1 Complexes to Chromatin, Inhibiting Histone-Remodeling Marks Critical for Transcriptional Activation Michaël Schnekenburger, Glenn Talaska, Alvaro Puga Molecular and Cellular Biology Histone ModificationsHistone MarksEpigenetic ChangeGeneticsDna Methylation	2007	145
Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition Annelyse Duvoix, Franck Morceau, Sylvie Delhalle, Biochemical Pharmacology Chemoprevention StrategyMedicineLipid PeroxidationApoptosisCell Death	2003	134
Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells Sérgio Valente, Yiwei Liu, Michaël Schnekenburger, Journal of Medicinal Chemistry Epigenetic ChangeDna MethylationCancer BiologyEpigeneticsSelective Non-nucleoside Inhibitors	2014	129
HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation Michaël Schnekenburger, Peng Li, Alvaro Puga Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression Histone ModificationsMolecular RegulationEpigenetic ChangeGeneticsEpigenetics	2007	126
Protein Kinase and HDAC Inhibitors from the Endophytic Fungus <i>Epicoccum nigrum</i> Mustapha El Amrani, Daowan Lai, Abdessamad Debbab, Journal of Natural Products Industrial MycologyHdac InhibitorsBiosynthesisBiochemistryFungal Cell Biology	2013	107
Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy Michaël Schnekenburger, Cindy Grandjenette, Jenny Ghelfi, Biochemical Pharmacology Hematological MalignancyChromatinChronic Myeloid LeukemiaMedicineApoptosis	2010	99
Genomewide Analysis of Aryl Hydrocarbon Receptor Binding Targets Reveals an Extensive Array of Gene Clusters that Control Morphogenetic and Developmental Programs Maureen A. Sartor, Michaël Schnekenburger, Jennifer Marlowe, Environmental Health Perspectives	2009	95
Epigenetics Offer New Horizons for Colorectal Cancer Prevention Michaël Schnekenburger, Marc Diederich Current Colorectal Cancer Reports	2012	92
Natural chalcones as dual inhibitors of HDACs and NF-κB Barbora Orlikova, Michaël Schnekenburger, Mire Zloh, Oncology Reports Systems PharmacologyMolecular PharmacologyMedicinal ChemistryAnti-inflammatoryChemoprevention Strategy	2012	83

Page 1